The Impact of Bacterial Co-Infection on Hospitalized Children with Human Rhinovirus and Human Metapneumovirus Infections: A Retrospective Analytical Cross-Sectional Study

Qing Wan, Yawei Li, Ying Cheng, Hongbo HuJundishapur 2023 · DOI

Abstract

Background: Human rhinovirus (HRV) and human metapneumovirus (hMPV) are common viral causes of pediatric respiratory tract infections. Bacterial co-infections frequently complicate these illnesses, but their impact on disease severity is not well understood. Objectives: This study aimed to compare the clinical features of HRV and hMPV mono-infections and assess the impact of bacterial co-infection on disease severity. Methods: A retrospective analytical cross-sectional study was conducted on hospitalized children (≤ 14 years) in 2022. Results: hMPV mono-infection generally exhibited more severe symptoms (fever, cough, pneumonia) than HRV, except in children ≥ 6 years. For HRV, bacterial co-infection significantly increased pneumonia rates, PICU admissions, and hospitalization length. No such significant difference was found for hMPV. Conclusions: hMPV mono-infection is inherently more severe than HRV mono-infection, but bacterial co-infection acts as a significant exacerbator for HRV infections.

Introduction

Acute respiratory infections (ARIs) remain a leading cause of pediatric hospitalization globally. While Human Rhinovirus (HRV) and Human Metapneumovirus (hMPV) are frequently identified, they are often treated similarly in clinical settings. However, understanding the distinct "clinical signatures" of these viruses and how they interact with secondary bacterial pathogens is critical for optimizing treatment strategies, such as the timely initiation of antibiotics or escalation of care. This study provides a data-driven comparison of these two viral pathogens and evaluates the impact of bacterial co-infection on clinical outcomes.

Methods

This retrospective study analyzed data from the Maternal and Child Health Hospital of Hubei Province in Wuhan, China, throughout 2022. The study included 1,978 children hospitalized with HRV and 1,117 with hMPV. Viral detection was performed using PCR capillary electrophoresis on nasopharyngeal secretions or alveolar lavage fluid. Bacterial co-infections were identified through cultures from sterile or non-sterile sites, with species identification via MALDI-TOF mass spectrometry. Researchers compared mono-infections against co-infections across demographics, clinical symptoms (fever, wheezing, rales), and outcomes (PICU admission, length of stay).

Results

HRV vs. hMPV Mono-infections

The study found that hMPV is generally the "heavier hitter" compared to HRV. Even as a mono-infection, hMPV was associated with higher rates of fever, cough, and pneumonia, particularly in children under six years old. Conversely, HRV was more frequently associated with wheezing, suggesting a different physiological impact on pediatric airways.

Table 1: Clinical characteristics of HRV vs. hMPV mono-infections across age groups.

The Impact of Bacterial Co-infection

A key finding was the disparity in how bacterial co-infection affected each virus. For HRV, the presence of bacteria significantly worsened clinical outcomes. Co-infected children had a higher proportion of pneumonia (76.2% vs. 50.8%), increased PICU admissions (12.7% vs. 3.1%), and longer hospitalizations (6.24 vs. 4.93 days) compared to those with HRV mono-infection ($P < 0.05$).

Table 3: Comparison of clinical outcomes between HRV mono-infection and bacterial co-infection.

In contrast, bacterial co-infection did not significantly alter the clinical course of hMPV infections. This suggests that hMPV may be inherently cytotoxic enough that additional bacterial damage does not statistically change the overall severity of the disease. Streptococcus pneumoniae was the most common bacterial co-pathogen identified in both groups.

Discussion and Conclusion

The study highlights that while hMPV mono-infections are typically more severe than HRV mono-infections, bacterial co-infection acts as a significant "force multiplier" for HRV. This synergy drastically worsens outcomes for HRV patients, whereas hMPV's high baseline pathogenicity appears to mask the impact of secondary bacterial infections.

Limitations of the study include its retrospective design and the potential for underestimated co-infection rates due to pre-hospitalization antibiotic use. Furthermore, the 2022 timeframe reflects a period of unique social distancing measures. Future prospective research is needed to explore the molecular mechanisms of these viral-bacterial interactions and determine if specific bacterial strains are more likely to drive severe outcomes in viral ARIs. In conclusion, clinicians should be particularly vigilant for bacterial co-infection in HRV cases, as it significantly escalates disease severity.

Summary updated

Abstract

Background: Human rhinovirus (HRV) and human metapneumovirus (hMPV) are common viral causes of pediatric respiratory tract infections. Bacterial co-infections frequently complicate HRV and hMPV illnesses in children, but the interactions between viral and bacterial pathogens and their impacts on disease severity are not well understood. Objectives: The present research aimed to analyze and compare the clinical features of HRV and hMPV mono-infections in hospitalized children and to assess the impact of bacterial co-infection on the disease severity of HRV and hMPV infections. Methods: The present retrospective analytical cross-sectional study was conducted to compare the clinical features between HRV and hMPV mono-infections and HRV and hMPV with bacterial co-infections in hospitalized children aged 14 years or younger. Results: Between January and December 2022, we investigated 1,978 children hospitalized with HRV infection, of which 1,529 had HRV mono-infection and 1,117 hospitalized with hMPV infection, among whom 910 had hMPV mono-infection. Compared to HRV, hMPV mono-infection exhibited more pronounced symptoms of fever, cough, and rales in most age groups, while HRV showed more wheezing. Except in patients ≥ 6 years old, hMPV was more associated with pneumonia and longer hospitalizations. In contrast to HRV mono-infections, children with bacterial co-infections had a higher proportion of coughs (P &lt; 0.001), pneumonia (P &lt; 0.001), pediatric intensive care unit (PICU) admissions (P &lt; 0.001), and longer hospitalizations (P = 0.003). Demographic characteristics, clinical presentation, diagnosis, and treatments showed no significant differences between patients with hMPV mono-infection and co-infection. Conclusions: Among hospitalized children, hMPV mono-infection resulted in more severe respiratory illnesses compared to HRV mono-infection. Bacterial co-infections exacerbated disease severity in HRV infections.
BibTeX
@inproceedings{wan2023impact,
  author = {Qing Wan and Yawei Li and Ying Cheng and Hongbo Hu},
  title = {{The Impact of Bacterial Co-Infection on Hospitalized Children with Human Rhinovirus and Human Metapneumovirus Infections: A Retrospective Analytical Cross-Sectional Study}},
  booktitle = {Jundishapur},
  year = {2023},
  doi = {10.5812/jjm-139106},
}
Figure